000 | 01195 a2200313 4500 | ||
---|---|---|---|
005 | 20250516090634.0 | ||
264 | 0 | _c20130121 | |
008 | 201301s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.3109/10428194.2012.676177 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJoerger, M | |
245 | 0 | 0 |
_aRational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cOct 2012 |
||
300 |
_a1867-75 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHuitema, A D R | |
700 | 1 | _aIllerhaus, G | |
700 | 1 | _aFerreri, A J M | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 53 _gno. 10 _gp. 1867-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2012.676177 _zAvailable from publisher's website |
999 |
_c21728897 _d21728897 |